Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
559
-
Total 13F shares, excl. options
-
17,594,322
-
Shares change
-
+329,195
-
Total reported value, excl. options
-
$5,456,889,651
-
Value change
-
+$105,134,710
-
Put/Call ratio
-
121%
-
Number of buys
-
264
-
Number of sells
-
-212
-
Price
-
$310.08
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q2 2017
645 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q2 2017.
ISHARES TR - ISHARES BIOTECH (IBB) has 559 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,594,322 shares
.
Largest 10 shareholders include MORGAN STANLEY (2,076,720 shares), BANK OF AMERICA CORP /DE/ (1,627,858 shares), CITIGROUP INC (1,329,939 shares), GOLDMAN SACHS GROUP INC (1,064,790 shares), UBS Group AG (607,434 shares), ALLIANCEBERNSTEIN L.P. (581,033 shares), BNP PARIBAS ARBITRAGE, SA (526,767 shares), CHURCHILL MANAGEMENT Corp (503,412 shares), JPMORGAN CHASE & CO (392,452 shares), and ROYAL BANK OF CANADA (379,836 shares).
This table shows the top 559 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.